Incliva

Noticias

INCLIVA coordinates the Spanish part of a European project to improve the treatment of patients with heart problems

INCLIVA HEALTH RESEARCH INSTITUTE VALENCIA BigData@Heart
INCLIVA is the only Spanish participant in the BigData@Heart project
Published on 12/07/2017.View more »

Genetics also influences the quality of bones

INCLIVA HEALTH RESEARCH INSTITUTE VALENCIA
Research carried out in collaboration with other Spanish centers and recently published in the Scientific Reports magazine concludes that two micro-RNAs can alert clinicians to the risk of osteoporosis and bone fracture.  
Published on 13/06/2017.View more »

The board of INCLIVA appoints Andrés Cervantes as its new General Director and Vicente de Juan as its Financial...

The board of INCLIVA appoints Andrés Cervantes as its new General Director and Vicente de Juan as its Financial Director.
INCLIVA’s board of trustees met this afternoon and agreed to appoint Andrés Cervantes as the new Director General of the Institute who, for now, will also assume the functions of the Scientific Director.  
Published on 10/05/2017.View more »

The INCLIVA Equality Plan obtains the “Making Business Equal in Opportunities” quality seal from the Valencian...

INCLIVA HEALTH RESEARCH INSTITUTE VALENCIA EQUALITY
INCLIVA, is the first research foundation to obtain the “Making Business Equal in Opportunities” quality seal, awarded by the Vice President and Department of Equality and Inclusive Policies at the Valencian regional government.     
Published on 22/04/2017.View more »

Award for the best R&D prize in ONCOLOGY at the 2016 BIC Awards

INCLIVA HEALTH RESEARCH INSTITUTE VALENCIA BEST IN CLASS ONCOLOGY
Álvaro Bonet and Ana Lluch received the prize for R&D in Oncology from representatives of the Best in Class awards organization.  
Published on 27/03/2017.View more »

A gene essential in the creation of resistances to the treatment of HER2 breast cancer is identified for the first time

INCLIVA HEALTH RESEARCH INSTITUTE VALENCIA
CCNE2 is the protein involved in HER2 breast cancer resistance.     
Published on 11/02/2017.View more »